Back to search

Article

Chromosomal microarray analyses from 5,778 patients with neurodevelopmental disorders and congenital anomalies in Brazil

2022-03-10

Abstract excerpt

<h4>ABSTRACT</h4> Chromosomal microarray analysis (CMA) has been recommended and practiced routinely since 2010 in USA and Europe as the first-tier cytogenetic test for patients with unexplained neurodevelopmental delay/intellectual disability, autism spectrum disorders, and/or multiple congenital anomalies. However, in Brazil, the use of CMA is still limited, due to its high cost and complexity of the combination...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ac05c3e9-f9b9-58f6-b405-388ff5b7253b
DOI
10.1101/2022.03.08.22272093
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Chromosomal microarray analyses from 5,778 patients with neurodevelopmental disorders and congenital anomalies in BrazilDOI 10.1101/2022.03.08.22272093
Chromosomal microarray analyses from 5778 patients with neurodevelopmental disorders and congenital anomalies in BrazilSemantic proximity
Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital AnomaliesSemantic proximity
Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of BrazilSemantic proximity
Diagnostic Utility of Chromosomal Microarray Analysis in a Turkish Pediatric Cohort: Insights from 1,022 Patients with Neurodevelopmental Disorders and Congenital Anomalies.Semantic proximity
Clinical evaluation of rare copy number variations identified by chromosomal microarray in a Hungarian neurodevelopmental disorder patient cohortSemantic proximity
Chromosomal microarray in postnatal diagnosis of congenital anomalies and neurodevelopmental disorders in Serbian patientsSemantic proximity
Genomic Landscape and Diagnostic Yield of Chromosomal Microarray Analysis in 471 Turkish Children with Neurodevelopmental Disorders and Congenital AnomaliesSemantic proximity
A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASDSemantic proximity
A Cohort Study of Individuals with Neurodevelopmental Disorders and/or Congenital Anomalies Investigated by High- Resolution Chromosomal Microarrays in Southern Brazil: The Significance of Autism Spectrum DisorderSemantic proximity
Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic servicesSemantic proximity
Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesSemantic proximity
The impact of chromosomal microarray on clinical management: a retrospective analysis.Semantic proximity
Select a neighboring publication to make it the new centre.